Hints and tips:
...The impending expiry of patents protecting Viagra and Lyrica, two of the company’s top-selling drugs, is the main reason that Pfizer will probably attempt a large takeover, argues Jeffrey Holford, a Jefferies...
...Jeffrey Holford, analyst at Jefferies, says the deal was “expensive by most conventional multiples’ at more than 12 times Actelion’s revenue forecast for 2017....
...“We see potential dislocation of Pfizer R&D efforts during the integration period,” says Andrew Baum, an analyst at Citigroup....
...According to Jeffrey Holford, an analyst at Jefferies, Ibrance is on track to be “one of the fastest oncology product launches ever”....
...Additional reporting by Andy Sharman This article has been amended to correct the spelling of Jeffrey Holford’s name....
...Jeffrey Holford, analyst at Jefferies, said there was not yet enough data to judge the effectiveness and safety of Medi4736 against rival products, but said there was a potential opening for AstraZeneca...
...Jeffrey Kindler, who became Pfizer’s chief executive, benefited from Lipitor’s expansion to be the world’s top-selling drug with $13bn in annual revenues....
...Andrew Baum, analyst at Citigroup, said he expected Pfizer would eventually prevail but predicted it would have to offer at least £50 a share with 40 per cent in cash to win AstraZeneca’s approval....
...Andrew Baum at Citi, who predicted the sale, argued it was good for both companies....
...L Frank Baum, who wrote The Wizard of Oz, was before that a journalist whose editorials for a Dakota newspaper argued the need to exterminate the local Sioux Indians....
...China in the 21st Century: What Everyone Needs to Know, by Jeffrey N....
...Frank Baum calls his villains The Wicked Witch of the West and The Wicked Witch of the East....
International Edition